Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
1.75 Fte (6)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
European CRO Federation (EUCROF)
EU Transparency Register
898445414948-91 First registered on 26 Nov 2014
Goals / Remit
The objective of EUCROF (the European CRO Federation), a non-profit organisation founded in 2005, is to promote Clinical Research by improving the knowledge, competence/expertise and skills of Contract/Clinical Research Organisations (CROs) in Europe.
The Federation represents and supports the interests of CROs in Europe towards regulatory bodies, pharmaceutical, biotech, medical device, patients associations and other healthcare-related entities, within the field of clinical research. As one of the stakeholders, EUCROF is interested in promoting and supporting high-quality clinical trials by observing internationally agreed ethical, technical and scientific principles. EUCROF organises and supports training and education programmes to increase the quality of clinical research and to improve collaboration and interaction amongst all stakeholders in the field in Europe. Active participation in international congresses and meetings further underlines the significant role of CRO (...)Main EU files targeted
During the last year, EUCROF has performed many activities as stakeholder, invited to represent the Contract Research Organisations point of view on many Clinical Research issues, new rules and regulations during formal meetings with the European Medicinal Agency (EMA), Paediatric Research Consortia, Patient Associations and Conferences on Clinical Research:
-EMA: EU clinical trials portal and Union database: meeting with stakeholders, Amsterdam
-EMA: Participation to UAT for EU Portal
- GCP Inspectors WG and interested parties Joint Meeting
-Enpr-EMA meetings
EUCROF has created 12 active working groups:
1. Clinical Trials Centres
2. Clinical Trials Legislation
3. Communication
4. Early Phase
5. Events and Training
6. Innovative Medicines
7. Medical Devices
8. New Technologies
9. Paediatrics
10. Patients' Associations
11. Pharmacovigilance
12. Real World Data & Digital Health
EUCROF held its 6th European Conference on Clinical Research in Madrid (Spain) on 7 & 8 February 2022.Address
Head Office
Pelmolenlaan 2, p
Woerden 3447 GW
NETHERLANDSEU Office
Pelmolenlaan 2, p
Woerden 3447 GW
NETHERLANDSWebsite
-
People
Total lobbyists declared
6
Employment time Lobbyists 50% 1 25% 5 Lobbyists (Full time equivalent)
1.75
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
The engaged members of the Executive Board:
Mrs Martine Dehlinger-Kremer (President)
Mr. Stefano Marini (Vice-President)
Mr. Simon Lee (Secretary)
Mr. Yoani Matsakis (Treasurer)
Mr. Christophe Golenvaux (Board Member)Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
The EUCROF is collaborating with further organizations:
1. Association of Clinical Research Organizations or ACRO (in the USA)
2. EFGCP, European Federation for Good Clinical Practice
3. EPF
Moreover, there is ongoing collaboration with representatives of the pharmaceutical industry, such as EFPIA.Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
100,000€ - 199,999€
Other financial info
The costs are low compared to the number and time of people involved because their contribution is mostly on a voluntary basis, without compensation
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Other activities
During the last year, EUCROF has performed many activities as stakeholder, invited to represent the Contract Research Organisations point of view on many Clinical Research issues, new rules and regulations during formal meetings with the European Medicinal Agency (EMA), Paediatric Research Consortia, Patient Associations and Conferences on Clinical Research
EUCROF has created and manages 12 active working groups:
1. Clinical Trials Centres
2. Clinical Trials Legislation
3. Communication
4. Early Phase
5. Events and Training
6. Innovative Medicines
7. Medical Devices
8. New Technologies
9. Paediatrics
10. Patients' Association
11. Pharmacovigilance
12. Real World Data & Digital Health
In this context, EUCROF is significantly progressing with its direct participation to the EMA GCP Inspectors Working Group (IWG), with the EUCROF WG on Clinical Trials in Paediatric Populations being invited to EMA meetings being part of working groups of Enpr-EMA and being an observer member of the Coordinating group of Enpr-EMA, with the WG on Clinical Trial Legislation analysing and suggesting changes to draft guidelines, concept papers or other legislation under public consultation.
Meetings
Meetings
None declared